2019
DOI: 10.1007/s00167-019-05568-2
|View full text |Cite
|
Sign up to set email alerts
|

Encouraging mid-term outcomes for arthroscopic autologous osteochondral transplant (OAT) in capitellum osteochondritis dissecans (OCD)

Abstract: Purpose The primary outcomes are the evaluation and quantiication of pain relief and improvement in range of motion after OAT in OCD. The secondary outcomes are: resuming of sport activities, evaluation of the ADL recovery rate and subjective evaluation of the quality of life improvement. Methods Nine patients, afected by an unstable and non-acute OCD lesion of the capitulum humeri, have been treated by the same surgeon. The patient mean age was 22.4 (16-45 years). All subjects were treated with the same surgi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…When lateral column involvement is more than 6 mm, OAT is strongly suggested [4,9]. OAT is the only technique that can address at the same time the articular cartilage and the subchondral bone pathology [21][22][23]. The plug can be customized to match the recipient site in shape, but not in cartilage thickness.…”
Section: • Osteochondral Autograft Transplant (Oat)mentioning
confidence: 99%
“…When lateral column involvement is more than 6 mm, OAT is strongly suggested [4,9]. OAT is the only technique that can address at the same time the articular cartilage and the subchondral bone pathology [21][22][23]. The plug can be customized to match the recipient site in shape, but not in cartilage thickness.…”
Section: • Osteochondral Autograft Transplant (Oat)mentioning
confidence: 99%
“…Arthroscopic OAT for the capitellum has encouraging midterm results. [54] Donor site morbidity is a drawback of any OAT procedure.…”
Section: Delayed Onset Ulnar Neuritis (Doun)mentioning
confidence: 99%
“…The physician-administered Mayo Elbow Performance Score (MEPS), also known as the Mayo Elbow Performance Index [ 13 ], is currently the most commonly used outcome measure of elbow impairments in clinical trials worldwide [ 14 ]. Despite the broad international utilization of the MEPS [ 14 19 ], it is described as not being adequately validated [ 25 ] and only a relatively small number of translations, and cross-cultural adaptations have been performed.…”
Section: Introductionmentioning
confidence: 99%